Pneumovax
Sponsors
Lillebaelt Hospital, Centre Hospitalier Universitaire De Poitiers, National Institute of Allergy and Infectious Diseases (NIAID), CIHR Canadian HIV Trials Network, VA Office of Research and Development
Conditions
AIDSAsthmaChronic Lymphocytic LeukemiaCrohns DiseaseHIVInfections, Streptococcus PneumoniaeKidney TransplantationLiver Transplantation
Phase 1
Early Versus Delayed Pneumococcal Vaccination in HIV
CompletedNCT00137605
Start: 2004-09-30End: 2007-10-31Updated: 2014-02-13
Dynamics of the Immune Response in Children to the 23-valent Pneumococcal Capsular Polysaccharide Vaccine (Pneumovax)
CompletedNCT03460730
Start: 2004-11-04End: 2006-07-03Updated: 2018-03-12
Phase 2
Phase 3
Phase 4
Antibody Production in Immune Disorders
TerminatedNCT00023504
Start: 2002-06-13End: 2021-10-14Updated: 2021-10-15
Humoral Determinants of Immunity to Pneumococcal Infection
CompletedNCT00304382
Start: 2003-01-01End: 2012-06-01Updated: 2017-09-05
Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool Asthmatics
CompletedNCT00836641
Start: 2006-10-31End: 2008-12-31Updated: 2013-09-02
Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients
CompletedNCT01781871
Start: 2013-01-31End: 2017-10-04Updated: 2017-10-05
Pneumococcal Vaccination of Crohn Patients
CompletedNCT01947010
Start: 2013-07-31End: 2014-08-31Updated: 2015-02-10
HEMATOVAC-Immunogenicity of an Anti-pneumococcal Combined Vaccination (PCV13+PPV23 versus PREVENAR20) in Lymphoma
RecruitingCTIS2024-517288-22-01
Start: 2021-01-29Target: 160Updated: 2025-10-23
Unknown Phase
BLYS and IFN in SLE
CompletedNCT00611611
Start: 2007-10-31End: 2009-04-30Updated: 2011-04-28
Systems Biology of PNEUMOVAX®23 and PREVNAR 13®
CompletedNCT01307449
Start: 2014-04-30End: 2017-07-31Updated: 2018-10-02
Perturbing of HIV Reservoir With Immune Stimulation
CompletedNCT02707692
Start: 2016-08-31End: 2022-01-31Updated: 2022-08-24